Loading...
Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
CONTEXT: Lipodystrophies are extreme forms of metabolic syndrome. Metreleptin was approved in the United States for generalized lipodystrophy (GLD) but not partial lipodystrophy (PLD). OBJECTIVE: The objective of the study was to test metreleptin's efficacy in PLD vs GLD and find predictors for...
Saved in:
| Published in: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Endocrine Society
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422900/ https://ncbi.nlm.nih.gov/pubmed/25734254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|